ISDA

Deposition Date 2020-11-16

Release Date 2021-02-24

Last Version Date 2023-10-18

Entry Detail

PDB ID:

7KQJ

Keywords:

TRANSCRIPTION/Agonist

Title:

CRYSTAL STRUCTURE OF RAR-RELATED ORPHAN RECEPTOR C (NHIS-RORGT(244-487)-L6-SRC1(678-692) IN COMPLEX WITH A NOVEL TRICYCLIC-CARBOCYLIC RORGT INVERSE AGONIST

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.65 Å

R-Value Free:

0.25

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Nuclear receptor ROR-gamma
Gene (Uniprot):RORC
Chain IDs:A
Chain Length:285
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P51449 Pfam ID:PF00104

Ligand Molecules

Z8G

Primary Citation

Tricyclic-Carbocyclic ROR gamma t Inverse Agonists-Discovery of BMS-986313.

Yang, M.G, Beaudoin-Bertrand, M, Xiao, Z, Marcoux, D, Weigelt, C.A, Yip, S, Wu, D.R, Ruzanov, M, Sack, J.S, Wang, J, Yarde, M, Li, S, Shuster, D.J, Xie, J.H, Sherry, T, Obermeier, M.T, Fura, A, Stefanski, K, Cornelius, G, Khandelwal, P, Karmakar, A, Basha, M, Babu, V, Gupta, A.K, Mathur, A, Salter-Cid, L, Denton, R, Zhao, Q, Dhar, T.G.M.Show

J.Med.Chem. 64 2714 2724 (2021)

PMID: 33591748 DOI: 10.1021/acs.jmedchem.0c01992

Abstact

SAR efforts directed at identifying RORγt inverse agonists structurally different from our clinical compound 1 (BMS-986251) led to tricyclic-carbocyclic analogues represented by 3-7 and culminated in the identification of 3d (BMS-986313), with structural differences distinct from 1. The X-ray co-crystal structure of 3d with the ligand binding domain of RORγt revealed several key interactions, which are different from 1. The in vitro and in vivo PK profiles of 3d are described. In addition, we demonstrate robust efficacy of 3d in two preclinical models of psoriasis-the IMQ-induced skin lesion model and the IL-23-induced acanthosis model. The efficacy seen with 3d in these models is comparable to the results observed with 1.

Legend

Protein

Chemical

Disease

Primary Citation of related structures